Ornithine tartaric acid molecular machine and liver-protecting and hangover-alleviating plant extract as well as preparation method and application thereof
Through the use of ornithine tartaric acid molecular machine, the problem of low extraction efficiency of flavonoid compounds has been solved, efficient and environmentally friendly extraction effects have been achieved, and the antioxidant and hangover effects of liver-protecting and hangover plants are significantly improved.
Patent Information
- Application Number
- CN202411327122.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-23
- Publication Date
- 2024-11-05
AI Technical Summary
现有提取技术中,黄酮类化合物的提取效率较低且存在溶剂安全性和环境友好性问题,难以平衡提取效率与成本效益。
Ornithine tartaric acid molecular machine is used, which selectively recognizes and connects flavonoids through hydrogen bonding and van der Waals forces to improve extraction efficiency, and prepares liver-protecting and sanitizing plant extracts through steps such as sonication and vacuum drying.
The yield of total flavonoids and quercetin is significantly improved, the extraction efficiency is 1.97 times that of water extraction, reducing dependence on petrochemical organic solvents, and the liver-protecting and sucking plant extracts are stable at room temperature and have excellent antioxidant Effects and hangover effects.
Smart Images

Figure CN118894785A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of molecular machines, and in particular to an ornithine tartrate molecular machine and a liver-protecting and alcohol-relieving plant extract, and a preparation method and application thereof. Background Art
[0002] As the pace of society accelerates, the frequency of drinking at work and social events increases, and people's demand for protecting liver health and alleviating alcohol damage is growing. There are many theories and practices on liver protection and hangover relief in traditional Chinese medicine, which provides a theoretical basis and traditional experience for the research and development of modern liver protection and hangover relief products.
[0003] Phyllanthus emblica, Pueraria lobata and ginger are all plants commonly used in traditional herbal medicine. They contain a variety of bioactive compounds, including quercetin (flavonoids). Flavonoids have excellent performance in sobering up and protecting the liver. First, it can promote alcohol metabolism: flavonoids may accelerate the decomposition of ethanol and its metabolite acetaldehyde by increasing the activity of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) in the liver, thereby reducing their accumulation in the body. Secondly, it has excellent antioxidant effects: free radicals and reactive oxygen species (ROS) are produced during alcohol metabolism, which can cause liver cell damage. Flavonoids have strong antioxidant capacity, can neutralize free radicals, reduce oxidative stress, and protect liver cells. Finally, it has anti-inflammatory effects: alcohol intake can trigger liver inflammation. Flavonoids reduce liver inflammatory damage by inhibiting the release of inflammatory mediators, such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β).
[0004] In the process of extracting flavonoids from Phyllanthus emblica, Pueraria lobata and Curcuma truncatula, choosing the right extraction technology and solvent is crucial to maintain their biological activity and improve the extraction efficiency. Although the traditional water extraction method is easy to operate, it is often limited by low extraction efficiency and more impurities. Relatively speaking, the organic solvent extraction method can improve the extraction efficiency, but the solvents used may have safety and environmental friendliness issues, and additional steps may be required for separation, purification and detection in subsequent processing, which undoubtedly increases the cost. Therefore, it is urgent to develop a green, environmentally friendly and efficient extraction solvent and extraction process. Traditional extraction processes include: heating and stirring, water bath extraction, etc. How to balance extraction efficiency and cost-effectiveness, and how to optimize the concentration and recycling of solvents are issues that need to be considered in current research and applications. Summary of the invention
[0005] One of the purposes of the present invention is to provide an ornithine tartrate molecular machine and a preparation method thereof, wherein the ornithine tartrate molecular machine can extract flavonoids in a plant raw material composition more efficiently and to a greater extent.
[0006] The second purpose of the present invention is to provide a liver-protecting and alcohol-relieving plant extract and its preparation method and application, to increase the total flavonoid yield and quercetin yield of the liver-protecting and alcohol-relieving plant extract, and to enhance the liver-protecting and alcohol-relieving effects.
[0007] In order to achieve the above object, the first aspect of the present invention provides an ornithine tartrate molecular machine, characterized in that it comprises an ornithine molecule and a tartaric acid molecule, wherein the amino group in the ornithine molecule is bonded to the hydroxyl group in the tartaric acid molecule through a hydrogen bond, and the distance between the amino group in the ornithine molecule and the hydroxyl group in the tartaric acid molecule is The distance between the carbonyl group in the ornithine molecule and the hydroxyl group in the tartaric acid molecule is
[0008] The ornithine tartrate molecular machine is capable of selectively recognizing and linking with flavonoids including quercetin;
[0009] The main structural unit of the ornithine tartrate molecular machine is shown in the following formula (a):
[0010]
[0011] The second aspect of the present invention provides a method for preparing the aforementioned ornithine tartrate molecular machine, comprising the following steps:
[0012] S1: in a protective gas atmosphere, ornithine and tartaric acid are contacted and reacted in a solvent, and then a first ultrasonic treatment is performed to obtain a precursor;
[0013] S2: Under the conditions of a temperature of 40° C. to 65° C. and a pressure of -0.05 MPa to -0.10 MPa, evaporating the precursor until no distillate is evaporated to obtain an intermediate;
[0014] S3: Under the conditions of a temperature of 30°C-80°C and a vacuum degree of -0.04MPa--0.1MPa, the intermediate is vacuum dried until the weight is constant to obtain an ornithine tartaric acid molecular machine.
[0015] The third aspect of the present invention provides a method for preparing a plant extract for protecting liver and relieving alcohol, comprising the following steps:
[0016] S4: mixing the plant raw material composition with the ornithine tartaric acid molecular machine solution and performing a second ultrasonic treatment to obtain a mixed solution;
[0017] The plant raw material composition comprises 30wt%-40wt% of Phyllanthus emblica, 30wt%-40wt% of Pueraria root, 25wt%-35wt% of Zingiber officinale and 5wt%-20wt% of auxiliary medicinal materials;
[0018] The solute of the ornithine tartrate molecular machine solution is the ornithine tartrate molecular machine described above, or the ornithine tartrate molecular machine prepared by the above preparation method;
[0019] S5: centrifuging the mixed solution, filtering the supernatant to obtain the liver-protecting and alcohol-relieving plant extract.
[0020] The fourth aspect of the present invention provides a liver-protecting and alcohol-relieving plant extract obtained by the aforementioned preparation method.
[0021] The fifth aspect of the present invention provides the use of the aforementioned liver-protecting and alcohol-relieving plant extract in the preparation of liver-protecting and alcohol-relieving foods, liver-protecting and alcohol-relieving health products, and liver-protecting and alcohol-relieving medicines.
[0022] The ornithine molecule and the tartaric acid molecule in the ornithine tartrate molecular machine provided by the present invention are combined by intermolecular forces (hydrogen bonds, van der Waals forces). The ornithine tartrate molecular machine can selectively extract quercetin when extracting flavonoid compounds. It is verified through practice and quantum chemical calculation that the ornithine tartrate molecular machine has better specific recognition ability for quercetin, and can significantly improve the yield of total flavonoids and quercetin compared with the monomer group and the physical blending group. The extraction efficiency is 1.97 times that of the water extraction method and 1.19 times that of 40wt% ethanol (the group with the best water and ethanol compound effect). It can solve the pain point problem of poor extraction efficiency of traditional solvents and reduce dependence on petrochemical organic solvents. It has certain positive significance for the deep development and utilization of plant resources.
[0023] The liver-protecting and alcohol-relieving plant extract prepared by the preparation method provided by the present invention has higher stability at room temperature and better antioxidant effect; it can also improve the ADH and ALDH activity effects in rat serum and liver, accelerate ethanol metabolism and reduce blood ethanol concentration; it can also inhibit the TG and TC expression effects in rat serum and liver, and has the best effect of improving lipid metabolism; whether it is taken before or after drinking, it has obvious alcohol-relieving effect, and the alcohol-relieving effect is better than that of a water extraction group and a physical blending group. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 The quantum chemical characterization diagram of the ornithine tartrate molecular machine provided in Preparation Example 1 of the present invention, wherein (a) is a structural optimization diagram of the ornithine tartrate molecular machine I, (b) is an ESP potential analysis diagram of the ornithine tartrate molecular machine I, and (c) is an IRI analysis diagram of the ornithine tartrate molecular machine I;
[0025] Figure 2 The quantum chemical characterization diagram of the interaction between the ornithine tartrate molecular machine I and the active substance quercetin provided in Preparation Example 1 of the present invention, wherein (a) is a structure optimization diagram, (b) is an ESP potential analysis diagram, and (c) is an IRI analysis diagram. DETAILED DESCRIPTION
[0026] The endpoints and any values of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.
[0027] As mentioned above, the first aspect of the present invention provides an ornithine tartrate molecular machine, comprising an ornithine molecule and a tartaric acid molecule, wherein the amino group in the ornithine molecule is bonded to the hydroxyl group in the tartaric acid molecule by a hydrogen bond, and the distance between the amino group in the ornithine molecule and the hydroxyl group in the tartaric acid molecule is The distance between the carbonyl group in the ornithine molecule and the hydroxyl group in the tartaric acid molecule is
[0028] The ornithine tartrate molecular machine is capable of selectively recognizing and linking with flavonoids including quercetin;
[0029] The main structural unit of the ornithine tartrate molecular machine is shown in the following formula (a):
[0030]
[0031] It should be noted that a molecular machine refers to a machine composed of molecular-scale materials that can perform a certain function. It has the characteristics of small size, diversity, self-assembly, adaptability, a wide range of polarity, and strong designability. Molecular machines combine the above components together through intermolecular interactions (hydrogen bonds, van der Waals forces, electrostatic attraction, etc.) and have a clear microscopic structure and macroscopic characteristics.
[0032] Emblica officinalis, Pueraria lobata and turmeric contain a variety of bioactive compounds, including quercetin (flavonoids). The ornithine tartrate molecular machine provided by the present invention can achieve specific site binding with flavonoids in Emblica officinalis, Pueraria lobata and turmeric, especially quercetin, through the action of hydrogen bonds and van der Waals forces. Specifically, the molecular machine selectively recognizes and connects with the hydroxyl and carbonyl groups in the quercetin molecule through non-covalent interactions such as strong hydrogen bonds and van der Waals forces, thereby further improving the total flavonoid yield and quercetin yield in Emblica officinalis, Pueraria lobata and turmeric.
[0033] According to some preferred embodiments of the present invention, in the ornithine tartrate molecular machine, the molar ratio of the ornithine molecule to the tartaric acid molecule is 1:(0.5-2). Particularly preferably, in the ornithine tartrate molecular machine, the molar ratio of the ornithine molecule to the tartaric acid molecule is 1:1. Under this preferred condition, the ornithine tartrate molecular machine has a stronger ability to selectively recognize and connect with quercetin, and can be used to extract a higher yield of quercetin and flavonoids from Phyllanthus emblica, Pueraria lobata and Zingiber officinale.
[0034] It should be noted that, in the present invention, "molar ratio" means "ratio of amount of substance".
[0035] The second aspect of the present invention provides a method for preparing the aforementioned ornithine tartrate molecular machine, comprising the following steps:
[0036] S1: in a protective gas atmosphere, ornithine and tartaric acid are contacted and reacted in a solvent, and then a first ultrasonic treatment is performed to obtain a precursor;
[0037] S2: Under the conditions of a temperature of 40° C. to 65° C. and a pressure of -0.05 MPa to -0.10 MPa, evaporating the precursor until no distillate is evaporated to obtain an intermediate;
[0038] S3: Under the conditions of a temperature of 30°C-80°C and a vacuum degree of -0.04MPa--0.1MPa, the intermediate is vacuum dried until the weight is constant to obtain an ornithine tartaric acid molecular machine.
[0039] According to some preferred embodiments of the present invention, in step S1, the protective gas is at least one of helium, argon, nitrogen and carbon dioxide.
[0040] According to some preferred embodiments of the present invention, in step S1, the solvent is ultrapure water. It should be noted that the amount of ultrapure water used is not particularly limited, as long as it can dissolve and mix ornithine and tartaric acid.
[0041] According to some preferred embodiments of the present invention, in step S1, the molar ratio of the amount of ornithine to the tartaric acid is 1:(0.5-2). Particularly preferably, the molar ratio of the amount of ornithine to the tartaric acid is 1:1. Under this preferred condition, the ornithine tartaric acid molecular machine prepared has a stronger ability to selectively recognize and connect with quercetin, and the yield of quercetin and flavonoids extracted from Phyllanthus emblica, Pueraria lobata and Zingiber officinale is higher.
[0042] According to some preferred embodiments of the present invention, in step S1, the reaction time of the contact reaction is 4h-6h, and the reaction temperature is 30°C-50°C.
[0043] More preferably, the contact reaction is accompanied by stirring.
[0044] According to some preferred embodiments of the present invention, in step S1, the first ultrasonic treatment satisfies at least the following conditions: the temperature of the ultrasonic field is 30°C-70°C, the ultrasonic frequency is 40kHz-80kHz, the ultrasonic power is 300W-900W, the ultrasonic time is 4h-8h, and the ultrasonic treatment is performed for 15s-25s every 3s-10s.
[0045] According to some preferred embodiments of the present invention, in step S2, the evaporation treatment is performed by rotary evaporation.
[0046] The third aspect of the present invention provides a method for preparing a plant extract for protecting liver and relieving alcohol, comprising the following steps:
[0047] S4: mixing the plant raw material composition with the ornithine tartaric acid molecular machine solution and performing a second ultrasonic treatment to obtain a mixed solution;
[0048] The plant raw material composition comprises 30wt%-40wt% of Phyllanthus emblica, 30wt%-40wt% of Pueraria root, 25wt%-35wt% of Zingiber officinale and 5wt%-20wt% of auxiliary medicinal materials;
[0049] The solute of the ornithine tartrate molecular machine solution is the ornithine tartrate molecular machine described above, or the ornithine tartrate molecular machine prepared by the above preparation method;
[0050] S5: centrifuging the mixed solution, filtering the supernatant to obtain the liver-protecting and alcohol-relieving plant extract.
[0051] According to some preferred embodiments of the present invention, in step S4, the concentration of the ornithine tartrate molecular machine in the ornithine tartrate molecular machine solution is 5wt%-40wt%.
[0052] It should be noted that the solvent of the ornithine tartrate molecular machine solution is water, and particularly preferably, the solvent of the ornithine tartrate molecular machine solution is ultrapure water.
[0053] According to some preferred embodiments of the present invention, in step S4, the concentration of the ornithine tartrate molecular machine in the ornithine tartrate molecular machine solution is 20wt%-40wt%. Under this preferred condition, the yield of quercetin and flavonoids in the prepared liver-protecting and alcohol-relieving plant extract is higher.
[0054] According to some preferred embodiments of the present invention, in step S4, the solid-to-liquid ratio of the mixed plant material composition and the ornithine tartaric acid molecular machine is 1 g: 20 mL-70 mL.
[0055] According to some preferred embodiments of the present invention, in step S4, the power of the second ultrasonic treatment is 100W-600W, the treatment time is 15min-120min, and the treatment temperature is 30-80°C.
[0056] According to some preferred embodiments of the present invention, in step S4, the auxiliary medicinal materials include at least one of wolfberry, mint, mulberry, inulin, and monk fruit.
[0057] According to some preferred embodiments of the present invention, in step S4, the plant raw material composition is in powder form, and the particle size of the traditional Chinese medicine composition is not greater than 0.18 mm.
[0058] According to some preferred embodiments of the present invention, in step S5, the centrifugal parameters of the centrifugal treatment are 3000r / min-10000r / min, the centrifugal time is 5min-15min, and the pore size of the filter membrane of the filtration treatment is not greater than 0.45μm. Particularly preferably, the pore size of the filter membrane of the filtration treatment is 0.25μm-0.45μm.
[0059] The fourth aspect of the present invention provides a liver-protecting and alcohol-relieving plant extract obtained by the aforementioned preparation method.
[0060] The fifth aspect of the present invention provides a use of the aforementioned liver-protecting and alcohol-relieving plant extract in the preparation of liver-protecting and alcohol-relieving foods, liver-protecting and alcohol-relieving health products, and liver-protecting and alcohol-relieving medicines.
[0061] According to some preferred embodiments of the present invention, the dosage forms of the liver-protecting and alcohol-relieving foods, liver-protecting and alcohol-relieving health products, and liver-protecting and alcohol-relieving medicines are at least one of aqueous solutions, emulsions, tablets, powders, and granules.
[0062] According to some preferred embodiments of the present invention, the liver-protecting and hangover-relieving food comprises a liver-protecting and hangover-relieving oral liquid, and the liver-protecting and hangover-relieving oral liquid is prepared by the following method:
[0063] The liver-protecting and hangover-relieving plant extract, vitamin B, anhydrous lactose, a sweetener, a flavoring agent, and a food thickener are mixed to obtain a liver-protecting and hangover-relieving oral liquid;
[0064] Among them, the amount of the liver-protecting and alcohol-relieving plant extract is 80-96 parts by mass, the amount of vitamin B is 2-5 parts by mass, the amount of anhydrous lactose is 1-4 parts by mass, the amount of the sweetener is 1-4 parts by mass, the amount of the flavoring is 1-3 parts by mass, and the amount of the food thickener is 1-3 parts by mass.
[0065] According to some preferred embodiments of the present invention, the sweetener is at least one of sucralose, aspartame, xylitol, sorbitol, mannitol, maltitol, cyclamate, and acesulfame potassium.
[0066] According to some preferred embodiments of the present invention, the flavoring agent is at least one of citric acid, taurine, propolis, honey, simple syrup, glycyrrhizic acid and stevioside.
[0067] According to some preferred embodiments of the present invention, the food thickener is at least one of gum arabic, sesbania gum, agar, sodium alginate, carrageenan, pectin or xanthan gum, sodium carboxymethyl cellulose (CMC) and carboxymethyl starch (sodium).
[0068] According to some preferred embodiments of the present invention, the liver-protecting and alcohol-relieving food also includes a liver-protecting and alcohol-relieving plant freeze-dried powder, which is prepared by the following method: vacuum freeze-drying the aforementioned liver-protecting and alcohol-relieving oral liquid at a temperature of minus 60°C to minus 30°C and a pressure of 10Pa to 60Pa to remove residual moisture and obtain dry liver-protecting and alcohol-relieving plant freeze-dried powder.
[0069] According to some preferred embodiments of the present invention, the liver-protecting and alcohol-relieving food also includes a liver-protecting and alcohol-relieving plant lozenge, which is prepared by the following method: adding microcrystalline cellulose to the aforementioned liver-protecting and alcohol-relieving plant freeze-dried powder, stirring for 10 minutes to 30 minutes, then adding magnesium stearate, stirring for 10 minutes to 30 minutes, and tableting to obtain the liver-protecting and alcohol-relieving plant lozenge.
[0070] Further preferably, in the preparation process of the liver-protecting and alcohol-relieving plant lozenges, the amount of the liver-protecting and alcohol-relieving plant freeze-dried powder is 75-90 parts by mass, the amount of the microcrystalline cellulose is 10-25 parts by mass, and the amount of the magnesium stearate is 1-3 parts by mass.
[0071] Further preferably, the tableting process is carried out in a tablet press, and the parameter settings of the tablet press at least meet the following conditions: a filling depth of 75% of the mold volume, a pre-compression pressure of 10MPa-20MPa, a main compression pressure of 100MPa-200MPa, a holding time of 10s-30s, and a demolding pressure of 5MPa-15MPa.
[0072] The present invention will be described in detail below by way of examples. The present invention will be described in detail below by way of examples. In the following examples, unless otherwise specified, the raw materials used are all common commercially available products.
[0073] In the following example, the weight composition ratio of the plant raw material composition is as follows: emblica: 35wt%, kudzu root: 30wt%, ginger: 25wt%, wolfberry: 5wt%, and monk fruit: 5wt%. The plant raw material composition is in the form of a powder with a particle size of no more than 0.18 mm, and the plant raw material composition is obtained by crushing each component, sieving it, and then mixing it.
[0074] Preparation Example 1
[0075] S1: Under a nitrogen atmosphere, ornithine and tartaric acid are contacted and reacted in ultrapure water at a molar ratio of 1:1, and then a first ultrasonic treatment is performed to obtain a precursor;
[0076] The contact reaction temperature is 30°C and the reaction time is 5h;
[0077] The first ultrasonic treatment meets the following conditions: ultrasonic field temperature of 45°C, ultrasonic frequency of 50kHz, ultrasonic power of 600W, ultrasonic treatment for 6h, ultrasonic treatment for 20s every 5s interval;
[0078] S2: Under the conditions of a temperature of 55° C. and a pressure of minus 0.07 MPa, the ornithine tartaric acid mixed solution is subjected to a rotary evaporation treatment until no distillate is evaporated to obtain an ornithine intermediate;
[0079] S3: Under the conditions of a temperature of 50° C. and a vacuum degree of minus 0.09 MPa, the intermediate is vacuum dried until the weight is constant to obtain ornithine tartaric acid molecular machine I.
[0080] For example, Figure 1 These are the quantum chemical characterization diagrams of ornithine tartrate molecular machine I, where (a) is the structure optimization diagram, (b) is the ESP potential analysis diagram, and (c) is the IRI analysis diagram.
[0081] like Figure 1 As shown in (a), the main structural unit of the ornithine tartrate molecular machine I is shown in the following formula (a):
[0082] The geometry optimization and frequency calculation of ornithine tartrate molecular machine I converged, and no imaginary frequency was found, indicating that the current structure is at the local minimum point of the potential energy surface and can exist stably. The hydroxyl group on the carboxyl group of tartaric acid is combined with the amino group and carbonyl group of ornithine through hydrogen bonds, and the distance between the hydroxyl group and the amino group and carbonyl group is Much shorter than the van der Waals radius.
[0083] As shown in (b) of Figure (1), the formation mechanism of the ornithine tartrate molecular machine was qualitatively analyzed by ESP. Black represents positive potential, white represents negative potential, and gray represents 0 potential. For ornithine, the carbonyl region is electropositive, and a large area surrounding the nitrogen atom is electropositive; for tartaric acid, the hydroxyl region on the carboxyl group is electronegative. After the molecular machine is formed, the electronegative region of ornithine and the electronegative region of tartaric acid attract each other to form a stable molecular machine structure.
[0084] The interaction region indicator (IRI) is used to characterize the van der Waals force, hydrogen bond, and steric repulsion of molecules, such as Figure 1 As shown in (c), in the interaction relationship, blue represents strong attractive interactions such as hydrogen bonds, and red represents strong steric hindrance. The stronger the steric hindrance, the more difficult it is for the atoms in the corresponding two regions to attract each other; the large green transition area represents the weak van der Waals interaction force. There is a large green interaction force area between ornithine and tartaric acid, indicating that there is a van der Waals force between them. And there are small blue discs between the hydroxyl group and the amino group and carbonyl group, indicating the existence of strong hydrogen bond interaction force.
[0085] Preparation Example 2
[0086] The molar ratio of the ornithine and the tartaric acid in the contact reaction in step S1 of preparation example 1 was adjusted to 2:1, and the parameters of the other steps were the same as those of preparation example 1, to obtain the ornithine tartaric acid molecular machine II.
[0087] Preparation Example 3
[0088] The molar ratio of the ornithine and the tartaric acid contacted in step S1 of preparation example 1 was adjusted to 1:2, and the remaining step parameters were the same as those of preparation example 1, to obtain ornithine tartaric acid molecular machine III.
[0089] Example 1
[0090] S4: mixing the plant raw material composition with the ornithine tartaric acid molecular machine solution I-1 and performing a second ultrasonic treatment to obtain a mixed solution;
[0091] The solute of the ornithine tartrate molecular machine solution is the ornithine tartrate molecular machine I prepared in Preparation Example 1, and the concentration of the ornithine tartrate molecular machine solution I-1 is 5 wt%;
[0092] The solid-liquid ratio of the plant raw material composition and the ornithine tartaric acid molecular machine solution I-1 is 1 g:40 mL, the power of ultrasound-assisted enhancement is 300 W, the treatment time is 30 min, and the treatment temperature is 50° C.;
[0093] S5: centrifuging the mixed solution, filtering the supernatant to obtain the liver-protecting and alcohol-relieving plant extract L1;
[0094] The centrifugal parameters of the centrifugal treatment are 10000 r / min, the centrifugal time is 12 min, and the pore size of the filter membrane of the filtration treatment is 0.45 μm.
[0095] Example 2
[0096] The concentration of the ornithine tartrate molecular machine solution I-1 in step S4 is adjusted from 5wt% to 10wt% to obtain ornithine tartrate molecular machine solution I-2; the remaining step parameters are the same as those in Example 1 to obtain the liver-protecting and alcohol-relieving plant extract L2.
[0097] The specific adjusted parameters are shown in Table 1 below.
[0098] Example 3
[0099] The concentration of the ornithine tartrate molecular machine solution I-1 in step S4 is adjusted from 5wt% to 20wt% to obtain ornithine tartrate molecular machine solution I-3; the remaining step parameters are the same as those in Example 1 to obtain the liver-protecting and alcohol-relieving plant extract L3.
[0100] The specific adjusted parameters are shown in Table 1 below.
[0101] Example 4
[0102] The concentration of the ornithine tartrate molecular machine solution I-1 in step S4 is adjusted from 5wt% to 30wt% to obtain ornithine tartrate molecular machine solution I-4; the remaining step parameters are the same as those in Example 1 to obtain the liver-protecting and alcohol-relieving plant extract L4.
[0103] The specific adjusted parameters are shown in Table 1 below.
[0104] Example 5
[0105] The concentration of the ornithine tartrate molecular machine solution I-1 in step S4 is adjusted from 5wt% to 40wt% to obtain ornithine tartrate molecular machine solution I-5; the remaining step parameters are the same as those in Example 1 to obtain the liver-protecting and alcohol-relieving plant extract L5.
[0106] The specific adjusted parameters are shown in Table 1 below.
[0107] Example 6
[0108] The ornithine tartrate molecular machine solution I-3 in step S4 is replaced by ornithine tartrate molecular machine solution II, wherein the solute of the ornithine tartrate molecular machine solution II is the ornithine tartrate molecular machine II prepared in Preparation Example 2, and the concentration of the ornithine tartrate molecular machine solution III is 20wt%, and the remaining step parameters are the same as Example 3, to obtain the liver-protecting and alcohol-relieving plant extract L6.
[0109] The specific adjusted parameters are shown in Table 1 below.
[0110] Example 7
[0111] The ornithine tartrate molecular machine solution I-3 in step S4 is replaced by ornithine tartrate molecular machine solution III, wherein the solute of the ornithine tartrate molecular machine solution III is the ornithine tartrate molecular machine III prepared in Preparation Example 3, and the concentration of the ornithine tartrate molecular machine solution III is 20wt%, and the remaining step parameters are the same as Example 3, to obtain the liver-protecting and alcohol-relieving plant extract L7.
[0112] The specific adjusted parameters are shown in Table 1 below.
[0113] Examples 8-12
[0114] The time of ultrasound-assisted enhanced treatment in step S4 was adjusted, and the parameters of other steps were the same as those in Example 3. The specific adjusted parameters are shown in Table 1 below, and liver-protecting and alcohol-relieving plant extracts L8, L9, L10, L11, and L12 were obtained respectively.
[0115] Examples 13-16
[0116] The temperature of the ultrasound-assisted enhanced treatment in step S4 was adjusted, and the parameters of the other steps were the same as those in Example 3. The specific adjusted parameters are shown in Table 1 below, and the liver-protecting and alcohol-relieving plant extracts L13, L14, L15, and L16 were obtained respectively.
[0117] Comparative Example 1
[0118] The ornithine tartrate molecular machine solution I-3 in step S4 was replaced with an ornithine solution with a concentration of 20 wt %, and the remaining step parameters were the same as those in Example 3 to obtain the liver-protecting and alcohol-relieving plant extract DL1.
[0119] Wherein, the ornithine solution is prepared by mixing ornithine with ultrapure water.
[0120] Comparative Example 2
[0121] The ornithine tartrate molecular machine solution I-3 in step S4 was replaced with a tartaric acid solution with a concentration of 20 wt %, and the remaining step parameters were the same as those in Example 3 to obtain the liver-protecting and alcohol-relieving plant extract DL2.
[0122] Wherein, the tartaric acid solution is prepared by mixing tartaric acid and ultrapure water.
[0123] Comparative Example 3
[0124] The ornithine tartrate molecular machine solution I-3 in step S4 was replaced with an ornithine tartrate mixed solution with a concentration of 20 wt %. The remaining step parameters were the same as those in Example 3 to obtain the liver-protecting and alcohol-relieving plant extract DL3.
[0125] The ornithine-tartrate mixture is prepared by mixing ornithine and tartaric acid with ultrapure water, wherein the amount of ultrapure water is such that the total mass concentration of ornithine and tartaric acid in the ornithine-tartrate mixture is 20wt%, and the molar ratio of the ornithine to the tartaric acid is 1:1.
[0126] Comparative Example 4
[0127] The ornithine tartaric acid molecular machine solution I-3 in step S4 was replaced with ultrapure water, and the remaining step parameters were the same as those in Example 3 to obtain the liver-protecting and alcohol-relieving plant extract DL4.
[0128] Comparative Examples 5-9
[0129] The ornithine tartaric acid molecular machine solution I-3 in step S4 was replaced with ethanol of different concentrations, ultrapure water was selected as the dilution solvent of ethanol, and the remaining step parameters were the same as those in Example 3 to obtain liver-protecting and alcohol-relieving plant extracts DL5, DL6, DL7, DL8, and DL9.
[0130] Test Example 1: The liver-protecting and alcohol-relieving plant extracts prepared in the above examples and comparative examples were tested for total flavonoids and quercetin content according to the following test methods. The specific test results are shown in Table 1 below.
[0131] Total flavonoids yield test method:
[0132] Drawing of rutin standard curve: accurately weigh 21.0 mg of rutin standard, dissolve it with 50% ethanol, and dilute it to a 100 mL volumetric flask to obtain a 0.210 mg / mL rutin standard solution. Draw 2.0 mL, 2.5 mL, 3.0 mL, 3.5 mL, and 4.5 mL of rutin standard solution into 5 25 mL colorimetric tubes. Then add 1.5 mL of 5% NaNO2 solution in turn, shake it well, let it stand for 5 min, add 1.5 mL of 10% Al(OH)3 solution, shake it well and let it stand for 5 min, add 15 mL of 10% NaOH solution, let it stand for 10 min, and finally add 50% ethanol solution to dilute it to 25 mL, and measure the absorbance at 510 nm. Draw the standard curve with absorbance as the ordinate and rutin mass concentration as the abscissa.
[0133] Pipette 1.0mL of the solution to be tested from the liver-protecting and alcohol-relieving plant extract, dilute it with 50% ethanol, and make up the volume in a 10mL volumetric flask. Pipette 1.0mL of the diluted solution to be tested and transfer it to a 25mL volumetric flask. Add 1.5mL of 5% NaNO2 solution in sequence, shake well, and let it stand for 5min; add 1.5mL of 10% Al(OH)3 solution, let it stand for 5min; add 15mL of 10% NaOH solution, let it stand for 10min, and measure the absorbance at 510nm.
[0134] The 50% ethanol solution was diluted to 25 mL, and the absorbance was measured at 510 nm. The 50% ethanol solution was used as the blank control solution, and the total flavonoid extraction rate was calculated according to Formula I.
[0135]
[0136] Where, F: total flavonoid yield, mg / g
[0137] C: Total flavonoids concentration, mg / mL
[0138] V: volume of sample solution, mL
[0139] X: dilution multiple
[0140] M: mass of plant raw material composition powder, g
[0141] Quercetin yield test method:
[0142] The prepared quercetin standard solution was diluted with 70% methanol (chromatographic grade) to 0.4, 0.8, 1.2, 1.6, and 2 mg / mL according to a series of concentration gradients. The liquid chromatography conditions for determining quercetin are: the mobile phase is methanol: phosphoric acid solution (pH≈3) = 60:40; the flow rate is 1 mL / min; the ultraviolet detection wavelength is 253 nm. The injection volume of each concentration of quercetin solution is 10 μL, and the injection order is from dilute to concentrated. The quercetin concentration (mg / mL) is used as the horizontal coordinate and the peak area is used as the vertical coordinate. The standard curve is drawn, the regression equation is calculated, and the linear relationship is finally obtained by fitting the curve. Each sample was measured in parallel 3 times, and the results were averaged to reduce the error. Finally, the concentration of quercetin, a plant extract for protecting liver and relieving alcohol, was obtained. The same formula was used to convert the yield according to the sample solution volume, dilution multiple, and the mass of the plant raw material composition powder. The specific results are shown in Table 1 below.
[0143] Table 1 Test results of total flavonoid yield and quercetin yield
[0144]
[0145]
[0146] From the test results of total flavonoid yield and quercetin yield in Examples 1-5, it can be seen that as the concentration of ornithine tartrate molecular machine increases from 5wt% to 40wt%, the total flavonoid yield and quercetin yield first gradually increase, and then show a slight downward trend after 20wt%.
[0147] From the test results of total flavonoid yield and quercetin yield in Examples 3, 6 and 7, it can be seen that the best effect is achieved when the molar ratio of ornithine to tartaric acid in the molecular machine is 1:1.
[0148] From the test results of total flavonoids yield and quercetin yield in Examples 3, 8-12, it can be seen that as the ultrasonic extraction time increases from 15 min to 30 min, the total flavonoids yield and quercetin yield gradually increase. However, as the time continues to increase, the total flavonoids and quercetin yields increase at a lower rate. Considering the extraction efficiency and extraction cost, it is appropriate to select an extraction time of 30 min.
[0149] From the test results of total flavonoids yield and quercetin yield in Examples 3 and 13-17, it can be seen that as the temperature increases from 30°C to 50°C, the total flavonoids yield and quercetin yield gradually increase, and then gradually decrease.
[0150] It can be seen from the test results of the total flavonoids yield and quercetin yield of Example 3 and Comparative Examples 1-3 that after the molecular machine is formed, the intermolecular forces (hydrogen bonds, van der Waals forces) of ornithine and tartaric acid have obvious advantages over the monomer group and the physical blending group, which effectively improves the yields of total flavonoids and quercetin, and has certain positive significance for the in-depth development and utilization of plant resources.
[0151] From the test results of total flavonoid yield and quercetin yield in Example 3 and Comparative Examples 4-9, it can be seen that the use of ornithine tartrate molecular machine can solve the pain point problem of low efficiency of traditional solvent extraction, and its extraction efficiency is 1.97 times that of water extraction and 1.19 times that of 40wt% ethanol (the best group of water and ethanol compounding effect). The use of ornithine tartrate molecular machine can reduce waste and reduce dependence on petrochemical organic solvents. On the other hand, by comparing the proportion of quercetin in total flavonoids, it can be found that ornithine tartrate molecular machine will selectively extract quercetin when extracting flavonoid compounds, and the quercetin acid content accounts for a high proportion, indicating that ornithine tartrate molecular machine has better specific recognition ability for quercetin.
[0152] Further, as an example, Figure 2 These are quantum chemical characterization diagrams of the interaction between ornithine tartrate molecular machine I and quercetin, where (a) is the structure optimization diagram, (b) is the ESP potential analysis diagram, and (c) is the IRI analysis diagram.
[0153] The possible mechanism of the high extraction efficiency of flavonoids including quercetin in the ornithine tartrate molecular machine system was studied by quantum chemical calculation characterization. Among them, the optimized structure of the interaction between the ornithine tartrate molecular machine and quercetin is as follows Figure 2 As shown in (a), both the geometry optimization and frequency calculation converged, and no imaginary frequency was found, indicating that the current structure is at the local minimum point of the potential energy surface and can exist stably. The distance between the carbonyl group of ornithine and the hydroxyl group on the carboxyl group of quercetin is much shorter than the van der Waals radius, which indicates that there is a strong hydrogen bond interaction between the ornithine tartrate molecular machine and quercetin. Figure 2 As shown in (b), the carbonyl regions of ornithine and quercetin are electronegative, while the hydroxyl groups are electronegative. When forming a stable structure, the electronegative region of the ornithine tartrate molecular machine and the electronegative region of quercetin attract each other, the binding region appears white, and the overall electrostatic potential is close to 0, thus forming a stable structure. The interaction region indicator function analysis of the ornithine tartrate molecular machine and quercetin is shown in Figure 2. Figure 2 As shown in (c), there are large green flake-shaped interaction regions between the ornithine tartrate molecular machine and quercetin, indicating the existence of van der Waals forces between them. At the same time, there are blue discs between the carbonyl group in the ornithine tartrate molecular machine and the hydroxyl group on the carboxyl group of quercetin, and the same is true between the hydroxyl group in the ornithine tartrate molecular machine and the carbonyl group of quercetin. This means that they have strong hydrogen bond interactions at these two sites, which contributes to the formation and stability of the entire system. ESP, structural optimization, and IRI can explain why the ornithine tartrate molecular machine system has a higher yield of quercetin and flavonoids.
[0154] Test Example 2: DPPH free radical scavenging test
[0155] The liver-protecting and alcohol-relieving plant extracts obtained in Example 3 and Comparative Examples 3, 4, and 8 were subjected to a DPPH free radical scavenging test according to the following method:
[0156] A sample tube (T), a sample background (T0), a DPPH tube (C) and a solvent background (C0) were set up. For each sample tube (T) of the liver-protecting and alcohol-relieving plant extract, three parallel tubes were set up, and liver-protecting and alcohol-relieving plant extract solutions of different concentrations (0.03125 mg / ml, 0.0625 mg / ml, 0.125 mg / ml, 0.25 mg / ml, 0.5 mg / ml, 1 mg / ml) were respectively configured. The solvent of the liver-protecting and alcohol-relieving plant extract solution was water.
[0157] Exemplarily, taking a 1 mg / ml liver-protecting and alcohol-relieving plant extract solution as an example, the following sample tube (T), sample background (T0), DPPH tube (C) and solvent background (C0) are set:
[0158] Sample tube (T): 1 mL of liver-protecting and alcohol-relieving plant extract solution (concentration of 1 mg / mL) + 2 mL of water + 1 ml of DPPH ethanol solution (concentration of 0.04 mg / mL);
[0159] Sample background tube (T0): 1 mL of liver-protecting and alcohol-relieving plant extract solution (concentration of 1 mg / mL) + 2 mL of water + 1 ml of 95 vol% ethanol solution;
[0160] DPPH tube (C): 3 mL of water + 1 ml of DPPH ethanol solution (concentration 0.04 mg / mL);
[0161] Solvent background tube (C0): 3 mL water + 1 ml 95% vol ethanol solution;
[0162] The solutions in the above reaction tubes were transferred into cuvettes, the absorbance was measured at 517 nm, and the DPPH radical scavenging rates of different liver-protecting and alcohol-relieving plant extracts were calculated by the following formula II. The specific results are shown in Table 2 below.
[0163]
[0164] Table 2 DPPH free radical scavenging rate test results
[0165]
[0166] As can be seen from Table 2, the liver-protecting and alcohol-relieving plant extract prepared in Example 3 of the present invention has a significant difference in scavenging DPPH free radicals (p < 0.05), indicating that the liver-protecting and alcohol-relieving plant extract prepared by the method provided by the present invention has a good scavenging effect on DPPH free radicals. With the increase of concentration, the DPPH scavenging rate gradually increases, and the liver-protecting and alcohol-relieving plant extract prepared in Example 3 of the present invention has a scavenging ability on DPPH free radicals that is much better than the liver-protecting and alcohol-relieving plant extracts prepared in Comparative Example 3 (physical blending group) and Comparative Example 4 and Comparative Example 8.
[0167] Test Example 3: Hydroxyl radical scavenging test
[0168] The liver-protecting and alcohol-relieving plant extracts prepared in Example 3 and Comparative Examples 3, 4 and 8 were respectively mixed with water to prepare liver-protecting and alcohol-relieving plant extract solutions, and hydroxyl radical scavenging tests were performed according to the following method. Specifically, the concentrations of the liver-protecting and alcohol-relieving plant extract solutions are shown in Table 3 below:
[0169] Set up the sample tube (A 样品 )、Loss pipe (A 损 )、Undamaged(A 未损), three parallel tubes are set up for each sample tube (T) of the liver-protecting and alcohol-relieving plant extract, and liver-protecting and alcohol-relieving plant extract solutions of different concentrations are respectively prepared, and the solvent for diluting the liver-protecting and alcohol-relieving plant extract solutions is water.
[0170] A 样品 : 1mL of o-phenanthroline ethanol solution (concentration of 5mmol / L) + 2mL of phosphate buffer (concentration of 0.2mol / L) + 1ml of liver-protecting and alcohol-relieving plant extract solution + 1mL of ferrous sulfate solution (5mmol / L) + 1mL of H2O2 solution (concentration of 0.1% v / v);
[0171] A 损 : 1mL of o-phenanthroline ethanol solution (concentration of 5mmol / L) + 2mL of phosphate buffer (concentration of 0.2mol / L) + 1ml of ultrapure water + 1mL of ferrous sulfate solution (5mmol / L) + 1mL of H2O2 solution (concentration of 0.1% v / v);
[0172] A 未损 : 1 mL of o-phenanthroline ethanol solution (concentration of 5 mmol / L) + 2 mL of phosphate buffer (concentration of 0.2 mol / L) + 1 mL of ferrous sulfate solution (5 mmol / L) + 2 mL of ultrapure water.
[0173] The solutions in the above reaction tubes were transferred into cuvettes, and the absorbance was measured at 536 nm. The hydroxyl radical scavenging rates of different liver-protecting and alcohol-relieving plant extracts were calculated by the following formula III. The specific results are shown in Table 3 below.
[0174]
[0175] Table 3 Hydroxyl radical scavenging rate test results
[0176]
[0177] As can be seen from Table 3, the liver-protecting and alcohol-relieving plant extract prepared in Example 3 of the present invention has a significant difference in the scavenging of hydroxyl free radicals (p < 0.05), indicating that the liver-protecting and alcohol-relieving plant extract prepared by the method provided by the present invention has a good scavenging effect on hydroxyl free radicals. With the increase of concentration, the hydroxyl scavenging rate gradually increases, and the liver-protecting and alcohol-relieving plant extract prepared in Example 3 of the present invention has a scavenging ability on hydroxyl free radicals that is much better than the liver-protecting and alcohol-relieving plant extracts prepared in Comparative Example 3 (physical blending group) and Comparative Example 4 and Comparative Example 8.
[0178] Test Example 4: Experimental comparative study on the liver-protecting and alcohol-detoxifying plant extracts in alcohol-detoxifying rats
[0179] 1. Reagents and medicinal materials
[0180] 56%vol Red Star Erguotou (Beijing Red Star Co., Ltd., batch number: 20200109); alcohol dehydrogenase (ADH) kit (batch number: ml003351), aldehyde dehydrogenase (ALDH) kit (batch number: m1003348), glutathione (GSH) kit (batch number: ml063305), glutathione S-transferase (GST) kit (batch number: ml058866) (Shanghai ELISA); triglyceride (TG) kit (batch number: A110-1-1), total cholesterol ( The kits were as follows: cholesterol (Tc) kit (batch number: A111-1-1), blood ethanol assay kit, malondialdehyde (MDA) kit (batch number: E036-1-1), superoxide dismutase (SOD) kit (batch number: A001-3-2); chloral hydrate (Tianjin Damao Chemical Reagent Factory, batch number: 20190915); 4% paraformaldehyde fixative (Saiguo Biotechnology Co., Ltd., batch number: 22105339); isopropanol (Sinopharm Chemical Reagent Co., Ltd., batch number: 80109218); oil red stain (batch number: G1015), hematoxylin-eosin stain (batch number: G1004), differentiation solution batch number: G1039, blueing solution batch number: G1040, glycerol gelatin mounting medium (batch number: G1402) (Saiweier Biotechnology Co., Ltd.).
[0181] 2. Experimental methods
[0182] Sixty healthy male rats were randomly divided into 6 groups, with 10 rats in each group, namely normal group (Control), model group (Molel), liver-protecting and alcohol-relieving plant extract L3 group (L3), liver-protecting and alcohol-relieving plant extract DL3 group (DL3), and liver-protecting and alcohol-relieving plant extract DL4 group (DL4).
[0183] Rats were gavaged with three groups of liver-protecting and alcohol-relieving plant extracts at a volume of 10 mL / kg for 7 consecutive days, and the normal group was gavaged with an equal volume of distilled water. 30 minutes after the administration, each drug-treated group and the model group were gavaged with 56% vol Red Star Erguotou liquor at 8 mL / kg, and the rats were gavaged with 8 mL / kg liquor at intervals of 30 minutes. The normal group was gavaged with an equal volume of distilled water. On the 7th day, blood was collected from the eye sockets of rats 1h, 2h, and 3h after the rats were gavaged with liquor. The blood samples were left to stand at room temperature for 1h, and the supernatant was aspirated after centrifugation at 4000 rpm for 10min at 4°C. It was stored in a refrigerator at -20°C for later use. After the rats were killed, the liver was quickly removed and weighed, the gross morphology of the liver was observed, and the liver index was calculated as shown in Formula IV. The specific results are shown in Table 4 below.
[0184] Liver index (%) = liver mass / last rat body weight × 100% Formula IV
[0185] Determination of blood ethanol concentration in rats The serum collected from rats 1h, 2h, and 3h after drinking wine was used to measure the blood ethanol concentration of rats using ultraviolet spectrophotometry according to the kit instructions. The specific results are shown in Table 5 below.
[0186] Determination of related indicators in rat serum and liver The levels of ADH and ALDH in rat serum and liver homogenate samples were determined by enzyme-linked immunosorbent assay according to the kit instructions. The specific results are shown in Table 6 below.
[0187] The microplate method was used to determine the levels of TG and TC. The specific results are shown in Table 7 below.
[0188] Table 4 Effects of liver-protecting and alcohol-relieving plant extracts on liver coefficients of drunken model rats
[0189] Group Liver index% Control 2.74 Molel 3.81 L3 2.93 DL3 3.22 DL4 3.60
[0190] As can be seen from Table 4, compared with the model group, the liver coefficient of rats in the liver-protecting and alcohol-relieving plant extract group L3 was significantly reduced, with a significant difference.
[0191] Table 5 Effects of liver-protecting and alcohol-relieving plant extracts on blood ethanol concentration in drunkenness model rats
[0192]
[0193] As can be seen from Table 5, compared with the model group, the blood ethanol concentration of the liver-protecting and alcohol-relieving plant extract group decreased 2h and 3h after gavage of rats with white wine, among which the blood ethanol concentration of the liver-protecting and alcohol-relieving plant extract L3 group was significantly reduced 1h, 2h, and 3h after gavage, and the reduction was significantly higher than that of the liver-protecting and alcohol-relieving plant extract DL3 and DL4 groups, indicating that the liver-protecting and alcohol-relieving plant extract L3 group has better alcohol-relieving effect in rats.
[0194] Table 6 Effects of liver-protecting and alcohol-relieving plant extracts on the activities of serum and liver alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) in drunken model rats
[0195]
[0196]
[0197] Ethanol is first metabolized to acetaldehyde by ADH and cytochrome P450 enzyme 2E1 (CYP2E1) in the liver, and acetaldehyde is metabolized to acetic acid by ALDH, and finally decomposed to H2O and CO2 through the tricarboxylic acid cycle. As can be seen from Table 6, compared with the normal group, the ADH and ALDH activities in the serum and liver of the rats in the model group were significantly decreased (P<0.05 or P<0.01). Compared with the model group, the ADH and ALDH activities in the serum and liver of the three groups of rats in the liver-protecting and alcohol-detoxifying plant extract were significantly increased (P<0.05), among which the ADH and ALDH activities in the serum and liver of the rats in the liver-protecting and alcohol-detoxifying plant extract L3 group were more significantly increased (P<0.05). This shows that the liver-protecting and alcohol-detoxifying plant extract L3 can accelerate ethanol metabolism and reduce blood ethanol concentration by significantly increasing the activity of ADH and ALDH.
[0198] Table 7 Effects of liver-protecting and alcohol-relieving plant extracts on the levels of triglyceride (TG) and total cholesterol (TC) in serum and liver of drunken model rats
[0199]
[0200] When ethanol causes liver damage, it will cause inflammatory swelling of liver tissue, increase liver weight, and increase liver coefficient. As can be seen from Table 7, compared with the normal group, the TG and TC contents in the serum and liver of rats in the model group were significantly increased (P<0.05 or P<0.01). The TG and TC contents in the serum and liver and the liver coefficient of rats in the model group increased, indicating that the administration of white wine to rats has caused liver cell damage and fat accumulation in the liver. Compared with the model group, the TG and TC contents in the serum and liver of the three groups of rats in the liver-protecting and alcohol-detoxifying plant extracts were significantly reduced (P<0.05), among which the TG and TC contents in the serum and liver of rats in the liver-protecting and alcohol-detoxifying plant extract L3 group were more significantly reduced (P<0.05), which has the best effect of improving lipid metabolism.
[0201] Test Example 5: Alcohol Sobering Performance Verification
[0202] 1. Preparation of oral liquid for liver protection and hangover relief:
[0203] The liver-protecting and hangover-relieving plant extract, vitamin B, anhydrous lactose, sweetener, flavoring agent, and food thickener are stirred for 30 minutes according to a certain weight component, and then filled into a bottle sterilized by high temperature, and sterilized again after filling to obtain a liver-protecting and hangover-relieving oral liquid;
[0204] Among them, the amount of the liver-protecting and alcohol-relieving plant extract is 87 parts by mass, the amount of vitamin B is 3 parts by mass, the amount of anhydrous lactose is 2 parts by mass, the amount of aspartame is 2 parts by mass, the amount of xylitol is 1 part by mass, the amount of honey is 3 parts by mass, and the amount of pectin is 2 parts by mass.
[0205] Among them, the liver-protecting and alcohol-relieving plant extracts L3, DL3, and DL6 correspond to the liver-protecting and alcohol-relieving oral liquids L3, DL3, and DL6, respectively.
[0206] 2. Preparation of oral lozenges for liver protection and hangover relief:
[0207] The liver-protecting and alcohol-relieving oral liquid is subjected to vacuum freeze-drying treatment at a temperature of minus 40° C. and a pressure of 50 Pa to remove residual water and obtain a dry liver-protecting and alcohol-relieving plant freeze-dried powder;
[0208] Microcrystalline cellulose was added to the liver-protecting and alcohol-relieving plant freeze-dried powder, and magnesium stearate was added after stirring for 25 minutes. After stirring for 15 minutes, the powder was tableted to obtain the liver-protecting and alcohol-relieving plant lozenges.
[0209] The tableting process is carried out in a tablet press, and the parameters of the tablet press are set as follows: filling depth: 75% of the mold volume.
[0210] Pre-compression pressure: 15MPa.
[0211] Main compression pressure: 100MPa.
[0212] Holding time: 15 seconds.
[0213] Demoulding pressure: 10MPa.
[0214] Among them, the liver-protecting and alcohol-relieving oral liquids L3, DL3 and DL6 correspond to the liver-protecting and alcohol-relieving oral lozenges.
[0215] 3. Experimental verification
[0216] 3.1 Drinking liver protection and alcohol detoxification oral liquid before drinking
[0217] In order to verify the hangover-relieving effects of the liver-protecting and hangover-relieving oral liquid and liver-protecting and hangover-relieving oral lozenges prepared in Example 3 and Comparative Examples 3, 6, and 10, 72 volunteers were recruited for the experiment. The volunteers were aged 25-30 years old and weighed 50-70 kg. The volunteers were in good health before the experiment. The 72 volunteers were divided into 6 groups, each with 12 people, including 6 men and 6 women.
[0218] Experiment 3-1 group before drinking: Volunteers drank 20 ml of the liver-protecting and alcohol-relieving oral liquid L3 made from the liver-protecting and alcohol-relieving plant extract L3 before drinking, and then took 2 mL / kg of Red Star Erguotou with an alcohol content of 56% vol, and finished drinking within 20 minutes.
[0219] Experiment 3-2 group before drinking: before drinking, the volunteers took the liver-protecting and alcohol-relieving oral lozenge L3 made with 10g of the liver-protecting and alcohol-relieving plant extract L3, and then took 2mL / kg of Red Star Erguotou with an alcohol content of 56%vol, and finished drinking within 20min.
[0220] Comparison group 3-1 before drinking: Volunteers drank 20 ml of the liver-protecting and alcohol-relieving oral liquid DL3 made from the liver-protecting and alcohol-relieving plant extract DL3 before drinking, and then took 2 mL / kg of Red Star Erguotou with an alcohol content of 56% vol, and finished drinking within 20 minutes.
[0221] Comparison group 3-2 before drinking: Volunteers took DL3, a liver-protecting and alcohol-relieving oral lozenge made with 20g of the liver-protecting and alcohol-relieving plant extract L3, before drinking, and then took 2mL / kg of Red Star Erguotou with an alcohol content of 56%vol, and finished drinking within 20min.
[0222] Comparison before drinking Group 6-1: Volunteers drank 20 ml of the liver-protecting and alcohol-relieving oral liquid DL6 made from the liver-protecting and alcohol-relieving plant extract DL6 before drinking, and then took 2 mL / kg of Red Star Erguotou with an alcohol content of 56% vol, and finished drinking within 20 minutes.
[0223] Comparison before drinking Group 6-2: Volunteers took DL6, a liver-protecting and alcohol-relieving oral lozenge made with 20g of the liver-protecting and alcohol-relieving plant extract DL6, before drinking, and then took 2mL / kg of Red Star Erguotou with an alcohol content of 56%vol, and finished drinking within 20min.
[0224] 30min and 60min after the volunteers drank the alcohol, the breath alcohol concentration was tested using a police breath alcohol tester. The average value of the test results of the 12 volunteers in each group was taken. The experimental results are shown in Table 8.
[0225] Table 8 Test results of exhaled gas alcohol concentration of volunteers in each group at different time periods
[0226]
[0227] As can be seen from Table 8, the oral liquid for protecting liver and sobering up and the oral lozenge for protecting liver and sobering up prepared by the present invention have a good sobering up effect when used after drinking, and the oral liquid is better than the tablet. The oral liquid for protecting liver and sobering up and the oral lozenge for protecting liver and sobering up provided by the present invention can significantly accelerate the decomposition rate of alcohol in the human body and reduce the absorption of ethanol by the gastrointestinal tract.
[0228] 3.2 Drinking alcohol-relieving and liver-protecting oral liquid after drinking
[0229] 72 volunteers were recruited for the experiment. The volunteers were aged 25-30 years old and weighed 50-70 kg. They were in good health before the experiment. The 72 volunteers were divided into 6 groups, each with 12 people, including 6 men and 6 women.
[0230] Experiment group 3-1 after drinking: the volunteers first took 2 mL / kg of Red Star Erguotou with an alcohol content of 56% vol, finished the drink within 20 minutes, and then immediately drank 20 ml of the liver-protecting and alcohol-detoxifying oral liquid L3 made from the liver-protecting and alcohol-detoxifying plant extract L3.
[0231] Experiment group 3-2 after drinking: the volunteers first took 2 mL / kg of Red Star Erguotou with an alcohol content of 56% vol, drank the wine within 20 minutes, and then immediately took the liver-protecting and alcohol-relieving oral lozenge L3 made with 10 g of the liver-protecting and alcohol-relieving plant extract L3.
[0232] Comparison group 3-1 after drinking: the volunteers first took 2 mL / kg of Red Star Erguotou with an alcohol content of 56% vol, finished the drink within 20 minutes, and then immediately drank 20 ml of the liver-protecting and alcohol-detoxifying oral liquid DL3 made from the liver-protecting and alcohol-detoxifying plant extract DL3.
[0233] Comparison group 3-2 after drinking: The volunteers first took 2 mL / kg of Red Star Erguotou with an alcohol content of 56% vol, drank the wine within 20 minutes, and then immediately took the liver-protecting and alcohol-relieving oral lozenge DL3 made with 10 g of the liver-protecting and alcohol-relieving plant extract L3.
[0234] Comparison after drinking Group 6-1: The volunteers first took 2 mL / kg of Red Star Erguotou with an alcohol content of 56% vol, finished the drink within 20 minutes, and then immediately drank 20 ml of the liver-protecting and alcohol-detoxifying oral liquid DL6 made from the liver-protecting and alcohol-detoxifying plant extract DL6.
[0235] Comparison of group 6-2 after drinking: the volunteers first took 2 mL / kg of Red Star Erguotou with an alcohol content of 56% vol, drank the wine within 20 minutes, and then immediately took the liver-protecting and alcohol-detoxifying oral lozenge DL6 made with 10 g of the liver-protecting and alcohol-detoxifying plant extract DL6.
[0236] 30min and 60min after the volunteers drank the liver-protecting and hangover-relieving oral liquid or took the liver-protecting and hangover-relieving oral lozenges, the breath alcohol concentration was tested with a police breath alcohol tester. The test results of the 12 volunteers in each group were averaged. The experimental results are shown in Table 9.
[0237] Table 9 Test results of exhaled gas alcohol concentration of volunteers in each group at different time periods
[0238]
[0239] As can be seen from Table 9, the oral liquid for protecting liver and relieving alcohol and the oral lozenge for protecting liver and relieving alcohol prepared by the present invention have a good hangover relieving effect when used after drinking, and the oral liquid is better than the tablet. The oral liquid for protecting liver and relieving alcohol and the oral lozenge for protecting liver and relieving alcohol provided by the present invention can significantly accelerate the decomposition rate of alcohol in the human body and reduce the absorption of ethanol by the gastrointestinal tract.
[0240] The preferred embodiments of the present invention are described in detail above, but the present invention is not limited thereto. Within the technical concept of the present invention, the technical solution of the present invention can be subjected to a variety of simple modifications, including the combination of various technical features in any other suitable manner, and these simple modifications and combinations should also be regarded as the contents disclosed by the present invention and belong to the protection scope of the present invention.
Claims
1. An ornithine tartrate molecular machine, characterized in that: The invention comprises an ornithine molecule and a tartaric acid molecule, wherein the amino group in the ornithine molecule is bonded to the hydroxyl group in the tartaric acid molecule through a hydrogen bond, and the distance between the amino group in the ornithine molecule and the hydroxyl group in the tartaric acid molecule is The distance between the carbonyl group in the ornithine molecule and the hydroxyl group in the tartaric acid molecule is The ornithine tartrate molecular machine is capable of selectively recognizing and linking with flavonoids including quercetin; The main structural unit of the ornithine tartrate molecular machine is shown in the following formula (a):
2. The ornithine tartrate molecular machine according to claim 1, characterized in that In the ornithine tartrate molecular machine, the molar ratio of the ornithine molecule to the tartaric acid molecule is 1:(0.5-2).
3. A method for preparing the ornithine tartrate molecular machine according to claim 1 or 2, characterized in that: The following steps are involved: S1: in a protective gas atmosphere, ornithine and tartaric acid are contacted and reacted in a solvent, and then a first ultrasonic treatment is performed to obtain a precursor; S2: Under the conditions of a temperature of 40° C. to 65° C. and a pressure of -0.05 MPa to -0.10 MPa, evaporating the precursor until no distillate is evaporated to obtain an intermediate; S3: Under the conditions of a temperature of 30°C-80°C and a vacuum degree of -0.04MPa--0.1MPa, the intermediate is vacuum dried until the weight is constant to obtain an ornithine tartaric acid molecular machine.
4. The preparation method according to claim 3, characterized in that: In step S1, the molar ratio of the ornithine to the tartaric acid is 1:(0.5-2); And / or, in step S1, the reaction time of the contact reaction is 4h-6h; And / or, in step S1, the first ultrasonic treatment satisfies at least the following conditions: the temperature of the ultrasonic field is 30°C-70°C, the ultrasonic frequency is 40kHz-80kHz, the ultrasonic power is 300W-900W, the ultrasonic time is 4h-8h, and the ultrasonic treatment is performed for 15s-25s every 3s-10s.
5. A method for preparing a plant extract for protecting liver and relieving alcohol, characterized in that: The following steps are involved: S4: mixing the plant raw material composition with the ornithine tartaric acid molecular machine solution and performing a second ultrasonic treatment to obtain a mixed solution; The plant raw material composition comprises 30wt%-40wt% of emblica, 30wt%-40wt% of kudzu root, 25wt%-35wt% of turmeric and 5wt%-20wt% of auxiliary medicinal materials; The solute of the ornithine tartrate molecular machine solution is the ornithine tartrate molecular machine according to claim 1 or 2, or the ornithine tartrate molecular machine prepared by the preparation method according to claim 3 or 4; S5: centrifuging the mixed solution, filtering the supernatant to obtain the liver-protecting and alcohol-relieving plant extract.
6. The preparation method according to claim 5, characterized in that: In step S4, the concentration of the ornithine tartrate molecular machine in the ornithine tartrate molecular machine solution is 5wt%-40wt%; And / or, in step S4, the solid-to-liquid ratio of the mixed plant material composition and the ornithine tartaric acid molecular machine is 1 g: 20 mL-70 mL; And / or, in step S4, the power of the second ultrasonic treatment is 100W-600W, the treatment time is 15min-120min, and the treatment temperature is 30-80°C; And / or, in step S4, the auxiliary medicinal material includes at least one of wolfberry, mint, mulberry, inulin, and monk fruit; And / or, in step S5, the centrifugal parameters of the centrifugal treatment are 3000 r / min-10000 r / min, the centrifugal time is 5 min-15 min, and the pore size of the filter membrane in the filtration treatment is not greater than 0.45 μm.
7. The liver-protecting and alcohol-relieving plant extract prepared according to claim 5 or 6.
8. Use of the liver-protecting and alcohol-relieving plant extract according to claim 7 in the preparation of liver-protecting and alcohol-relieving foods, liver-protecting and alcohol-relieving health products, and liver-protecting and alcohol-relieving medicines.
9. The use according to claim 8, characterized in that: The dosage forms of the liver-protecting and alcohol-relieving food, liver-protecting and alcohol-relieving health care product, and liver-protecting and alcohol-relieving medicine are at least one of aqueous solution, emulsion, tablet, powder, and granule.
10. The use according to claim 8 or 9, characterized in that: The liver-protecting and hangover-relieving food comprises a liver-protecting and hangover-relieving oral liquid, and the liver-protecting and hangover-relieving oral liquid is prepared by the following method: The liver-protecting and hangover-relieving plant extract, vitamin B, anhydrous lactose, a sweetener, a flavoring agent, and a food thickener are mixed to obtain a liver-protecting and hangover-relieving oral liquid; Among them, the amount of the liver-protecting and alcohol-relieving plant extract is 80-96 parts by mass, the amount of vitamin B is 2-5 parts by mass, the amount of anhydrous lactose is 1-4 parts by mass, the amount of the sweetener is 1-4 parts by mass, the amount of the flavoring is 1-3 parts by mass, and the amount of the food thickener is 1-3 parts by mass.
